Allogeneic hematopoietic stem cell transplantation in Hodgkin lymphoma: a systematic review and meta-analysis. - Wikidata - wikimedia - TriplyDB

Allogeneic hematopoietic stem cell transplantation in Hodgkin lymphoma: a systematic review and meta-analysis.

Allogeneic hematopoietic stem cell transplantation in Hodgkin lymphoma: a systematic review and meta-analysis.

http://www.wikidata.org/entity/Q37388718

about

Advances in the pathophysiology and treatment of relapsed/refractory Hodgkin's lymphoma with an emphasis on targeted therapies and transplantation strategies Cellular Therapies for Treatment of Radiation Injury: Report from a NIH/NIAID and IRSN Workshop.PD-1 blockade for relapsed lymphoma post-allogeneic hematopoietic cell transplant: high response rate but frequent GVHD.Hodgkin's Lymphoma - evaluation of patients submitted to Autologous transplantation of hematopoietic cells in the Hematology Service of the Hospital Walter Cantídio - Fortaleza, Brazil.Checking up on checkpoint inhibitors.Vorinostat plus tacrolimus/methotrexate to prevent GVHD after myeloablative conditioning, unrelated donor HCT.Fatal graft-versus-host disease after allogeneic stem cell transplantation in a patient recently exposed to nivolumab.Hodgkin lymphoma: A review and update on recent progress.Safety of hematopoietic cell infusion in children with malignant and non-malignant diseases.Anti-PD-1 Antibodies as a Therapeutic Strategy in Classical Hodgkin Lymphoma.

P2860

Q33886267-C46EAD52-DB3A-4CDA-B339-C4BB6A0851E1 Q38730028-0C0A0AC8-708D-4257-AFA7-E17982A48AC5 Q40216708-8E26CFBF-02C5-474B-8C0F-DF42AF3AC35E Q40422018-188B420D-320A-4718-8159-A9DD0666C163 Q41017116-2463DFF6-58B2-46F6-9BC9-74ECC127B741 Q47104749-3E733EBF-E220-4982-9296-3B639F9ED191 Q47364293-27D2EC50-4BAE-4789-9823-5F604214EFB0 Q47807176-A0BDEA7D-E254-40AF-8EE3-06724BBBAB74 Q48169085-B7B8C9FD-8749-4A28-81CD-A54FE08B924C Q48689919-766D4968-7C10-47E8-B38B-2246B960DC9E

P2860

Allogeneic hematopoietic stem cell transplantation in Hodgkin lymphoma: a systematic review and meta-analysis.

http://www.wikidata.org/entity/Q37388718

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 04 January 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Allogeneic hematopoietic stem ...... atic review and meta-analysis.

@en

Allogeneic hematopoietic stem ...... atic review and meta-analysis.

@nl

type

label

Allogeneic hematopoietic stem ...... atic review and meta-analysis.

@en

Allogeneic hematopoietic stem ...... atic review and meta-analysis.

@nl

prefLabel

Allogeneic hematopoietic stem ...... atic review and meta-analysis.

@en

Allogeneic hematopoietic stem ...... atic review and meta-analysis.

@nl

P1433

Q37388718-ECE0B6D5-8396-4336-A8E7-BA90CD03AE13

P1476

Q37388718-6D426B75-EF1E-4018-9854-95A9EF33E577

P2093

Q37388718-2C9658D5-2B0A-4CD2-9523-F650C3A3811B

Q37388718-762909B7-D7A9-4275-8FA0-D7E4C0EF2C83

Q37388718-988F8E40-CB14-4E3A-A1D0-D18250F66AB1

P2860

Q37388718-0C4449AD-65D0-4E86-96EB-277CFA173775

Q37388718-1208ACFA-1C20-446F-8941-790132C833D2

Q37388718-140D1203-AF42-468C-BDB8-97CD3B7A2DD5

Q37388718-15D38E88-25C5-423A-9488-AB36CDA1FF0F

Q37388718-1A83BBC1-7659-4120-B134-5F940D1311A6

Q37388718-25F6BDAF-ED18-4E10-87E4-60DF2C62C9D4

Q37388718-26F3DF18-31A7-4D15-8423-09056EE387FE

Q37388718-299B0200-FAE6-45ED-B718-02138B3233DC

Q37388718-359D33C7-5914-420F-B330-2657346EB440

Q37388718-42DB8EFC-7430-4CF8-842C-037FE7DBD107

P2888

Q37388718-EB960DE1-CADE-4441-958B-3FCBE79191F4

P304

Q37388718-AD6506FB-3943-40ED-BC26-5E3959099852

P31

Q37388718-55a1a3e4-4e50-4f07-8a97-24d7d9e287f8

Q37388718-D3CA96F9-2F74-4D29-A30A-5AA801F02825

P356

Q37388718-DED6527B-4853-4762-9F17-1B0F2F91B1ED

P407

Q37388718-2EB711F6-3458-4B76-8F30-A6C93751741D

P433

Q37388718-F2F19505-E525-4D27-9BF7-09A552108C62

P478

Q37388718-5B9E4A8B-153D-4A82-A820-E4F913A2D14D

P577

Q37388718-3345DBAF-800B-450A-AE69-A56017D0F20A

P6179

Q37388718-7F354BD1-2606-4B21-B87C-570D32B37434

P698

Q37388718-605AB7B4-15EA-4D24-9A5C-4FD9C189E803

P921

Q37388718-F6426D6D-04F5-4C71-9B26-CB55498D9A13

P932

Q37388718-0D040B00-978D-4A4B-A0CC-A5BD17202059

P356

P1433

Bone Marrow Transplantation

P1476

Allogeneic hematopoietic stem ...... atic review and meta-analysis.

@en

P2093

A F Cashen

http://www.w3.org/2001/XMLSchema#string

A Rashidi

http://www.w3.org/2001/XMLSchema#string

M Ebadi

http://www.w3.org/2001/XMLSchema#string

P2860

High-dose chemotherapy followed by autologous stem cell transplantation for patients with relapsed/refractory Hodgkin lymphoma

Meta-analysis in clinical trials

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Allogeneic or autologous stem cell transplantation (SCT) for relapsed and refractory Hodgkin's disease and non-Hodgkin's lymphoma: a single-centre experience.

Unrelated donor reduced-intensity allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma.

Brentuximab vedotin is associated with improved progression-free survival after allogeneic transplantation for Hodgkin lymphoma

Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial.

Fludarabine-melphalan as a preparative regimen for reduced-intensity conditioning allogeneic stem cell transplantation in relapsed and refractory Hodgkin's lymphoma: the updated M.D. Anderson Cancer Center experience.

Gemcitabine, fludarabine and melphalan as a reduced-intensity conditioning regimen for allogeneic stem cell transplant in relapsed and refractory Hodgkin lymphoma: preliminary results

Outcomes in relapsed Hodgkin's lymphoma treated with autologous and allogeneic hematopoietic cell transplantation at the Pontificia Universidad Católica de Chile.

P2888

P304

521-528

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BMT.2015.332

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

51

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1036679457

http://www.w3.org/2001/XMLSchema#string

P698

26726948

http://www.w3.org/2001/XMLSchema#string

P921

P932

5092068

http://www.w3.org/2001/XMLSchema#string